Growing need of Clinical Data, PMCF & Registries for Devices Post Market Clinical Follow Up (PMCF) studies are a critical component of the clinical evidence.

Slides:

Advertisements

Similar presentations

Mary Ellen Turner MD, MPH Vice-President

Advertisements

Building a Cradle-to-Grave Approach with Your Design Documentation and Data Denise D. Dion, EduQuest, Inc. and Gina To, Breathe Technologies, Inc.

And the provisions of….. the Medical Devices Regulations Medical Devices Agency.

Overview of Device Regulations David Arvelo Small Business Representative.

Susan Boynton, VP, Global Regulatory Affairs, Shire

CE Regulation Service PROLAB Tech Rev 1 Machinery Directive Flow Chart A brief guide.

Options for Regulation and the Impact of Regulation on the Marketplace 29 November 2005 Alan Kent

© Safeguarding public health Implementing Medical Device Regulation and Maintaining Patient Safety Name Nicola Lennard Date October 2011.

© Safeguarding public health BIOABSORBABLE STENTS: REGULATORY ISSUES DR SUSANNE LUDGATE Clinical Director Medicines and Healthcare products Regulatory.

CE marking Catriona Blake Team Manager, Imaging, acute and community care.

Medical Device Revisions Case Study Phil Brown 20th September 2012.

Overview of Medical Devices Sector Saudi Food and Drug Authority (Saudi Arabia) Dr. Saleh Al Tayyar Director General Medical Devices Sector Saudi Food.

CA 101 Certification and Registration ANSI Annual Conference 2002 by: Gordon Gillerman Manager Governmental Services Underwriters Laboratories

Slots/Windows of Opportunities HTA – Medical Devices Dr. Wolfgang Ecker EUnetHTA, Rome,

Changes to the Therapeutic Goods Act and its implications Prepared by: Anna Frazer Prosthetist Hunter Prosthetics & Orthotics Service 10 th November 2006.

PATRICIA KERBY, MPA HUMAN SUBJECTIONS PROTECTION COMPLIANCE OFFICER OFFICE OF RESEARCH COMPLIANCE What are the FDA’s expectations in 2010?

Towards an Industry Advisory Group An Open Round-Table Conversation 19 May 2009 Do not copy or reproduce without express written permission of Foresight.

UPCOMING CHANGES TO IN-VITRO DIAGNOSTICS (IVDs) AND LABORATORY DEVELOPED TESTS (LDTs) REGULATIONS Moj Eram, PhD November 5, 2015.

WORKSHOP ON ACCREDITATION OF BODIES CERTIFYING MEDICAL DEVICES INT MARKET TOPIC 6 CH 5 ISO MANAGEMENT RESPONSIBILITY Philippe Bauwin Medical.

Workshop on conformity assessment procedures and certification of medical devices INT MARKT Kyiv, November 2011 Conformity assessment of medical.

rSDV offers the best alternative option to altogether reduce onsite monitoring activities, how to maintain subject privacy in the process of collecting source documents and what 21 CFR Part 11 requires, strategies for remote review of source documents at

Clinical aspects of medical device development

Clusters working group COM/CAMD New Regulations

Medical Devices Regulation

Update on EU regulatory developments

Industry Implementation Priorities & Challenges COM/CAMD Stakeholders meeting on the new MD and IVD Regulations 9 March, 2017 John Brennan Director.

Flowchart on overview of requirements

FDA's Two New Draft Guidance on Software and Device

Rachel Neubrander, PhD Division of Cardiovascular Devices

Dartmouth Human Research Protection Program (HRPP) Data Safety Monitoring and Reporting requirements Brown Bag Series: Noon / First Tuesday of the Month.

Australian Jurisdictional Update March 2017

CA 101 Certification and Registration

Quality Reporting Office Hours

Regulatory Basics: Europe and the CE Mark

EudraVigilance.

Nicole Denjoy COCIR Secretary General

HITSP 2009 TC Timeline Overview

DIA Clinical Safety and Pharmacovigilance Community

Reasonable Assurance of Safety and Effectiveness: An FDA Division of Cardiovascular Devices Perspective Bram Zuckerman, MD, FACC Director, FDA Division.

Adverse Event Reporting: Trials and Tribulations

Generic Medicines.

Lessons Learned Through HBD: The Regulator’s View - US FDA

DDi is organizing the webinar on Vendor/CRO Oversight How effectively are you doing?. This webinar is planned to focus on vendor oversight plan, as well as strategies by identifying critical elements required and also aligning proper techniques of risk ma

MakroCare is organizing the webinar on Importance & Requirements of Clinical Evaluation for CER. This webinar is planned to focus on ensuring that clinical data are evaluated in a systematic and objective way, that the benefit/risk profile is acceptable a

MakroCare is organizing the webinar on Device Registries as PMCF tools. This webinar will provide an overview of PMCF requirements, outline elements of a well-designed registry and offer advice about known, potential pitfalls.

Medical Device PMS & PMCF: Challenges & Opportunities The new 2017/745/EU Medical Device Regulations (MDR-2020) require increased emphasis on Post- Market.

Risk Management EU MDR Perspective Risk management is understood as a continuous iterative process throughout the entire lifecycle of a device, requiring.

New European Medical Device Regulations – major changes that will affect all devices Rene van de Zande EMERGO | President & CEO

Streamlining IRB Procedures for Expanded Access

Date (include day of the week)

03/12/2018 Update - EU Medical Device Regulation Utah Life Science Summit November 2015 Paul Brooks Senior Vice President Healthcare Solutions.

Regulatory Views on Pathology Results November 5, 2015

Orienteering event here on Wednesday 24th April, 6pm

FDA Ratings for Medications Taken During Pregnancy (Est. 1979)

Regulation of Medical Products & Patient Safety- A Narrative Review

Quality and Regulatory Planning – the way forward?

A Practical Introduction to the Clinical Evaluation Report

Medical Device Design and Development

Name of Event Name of Event

Patient Involvement in the Development and Safe Use of

Clinical Research Association TURKEY

NEW MDR Regulatory Context. NEW MDR Regulatory Context.

Evidence standards for device approval: Regulatory perspectives

MEDICAL DEVICES CONTROL SYSTEM IN INDONESIA

Dr Manisha Shridhar Regional Advisor WHO-SEARO

Regulation in South-East Asia Joint Drugs Controller (India)

Compounded Drugs and Lack of Premarket FDA-Approval

All Professionals are involved in

USPS 2019 Informed Delivery Promotion

Presentation transcript:

Growing need of Clinical Data, PMCF & Registries for Devices Post Market Clinical Follow Up (PMCF) studies are a critical component of the clinical evidence required to comply with the new European regulations. As Clinical Evidence Reports (CERs) encounter more and more scrutiny by Notified Bodies (NBs), the gaps surrounding past PMCF work are becoming more evident. "Passive" collection of adverse events, complaints and the like may not be sufficient any longer to demonstrate conformity to the Essential Requirements and to the future Medical Device Regulation (MDR). This webinar will review emerging PMCF, Registry needs in this era of pre-MDR business risk evaluations. Learning objectives: Clearly define PMCF, Registry needs for Devices Apply CER gaps in safety and performance clinical data to PMCF & registry designs Differentiate adequate PMCF plans from less than adequate PMCF plans Alternate methods of getting Clinical data for your Devices

About Our Speaker Dr. Joy Frestedt Regulatory & Clinical Expert, Medical Device Date & Time: Wednesday, Nov 15, 2017 |11 AM to 12 noon EST/4 PM to 5 PM CET Register here: need-of-clinical-data-pmcf-registries-for-devices need-of-clinical-data-pmcf-registries-for-devices